1. Home
  2. Labeler Index
  3. Glaxosmithkline Llc
  4. 58437-027
  5. NDC Package Code: 58437-027-00 Dolutegravir And Lamivudine

NDC Package 58437-027-00 Dolutegravir And Lamivudine

Tablet, Film Coated - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is an UNFINISHED DRUG part of the official NDC directory. Unfinished drugs include products like active ingredients some of which are used in bulk for further processing or compounding. The FDA requires a list of these drugs manufactured in a U.S. commercial distribution facility.

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
58437-027-00
Package Description:
38550 TABLET, FILM COATED in 1 DRUM
Product Code:
58437-027
Non-Proprietary Name:
Dolutegravir And Lamivudine
Substance Name:
Dolutegravir Sodium; Lamivudine
11-Digit NDC Billing Format:
58437002700
Product Type:
Drug For Further Processing
Labeler Name:
Glaxosmithkline Llc
Dosage Form:
Tablet, Film Coated - A solid dosage form that contains medicinal substances with or without suitable diluents and is coated with a thin layer of a water-insoluble or water-soluble polymer.
Active Ingredient(s):
  • DOLUTEGRAVIR SODIUM 50 mg/1
  • LAMIVUDINE 300 mg/1
    • Sample Package:
    N/A
    Marketing Category:
    DRUG FOR FURTHER PROCESSING - A drug (other than the bulk ingredient API) that is in an interim stage of manufacture, processing, preparation, or packaging, and not ready for human or animal use.
    Start Marketing Date:
    01-01-2022
    Listing Expiration Date:
    12-31-2025
    Exclude Flag:
    N
    Unfinished Product:
    Yes
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 58437-027-00?

    The NDC Packaged Code 58437-027-00 is assigned to an UNFINISHED drug package of 38550 tablet, film coated in 1 drum of Dolutegravir And Lamivudine, drug for further processing labeled by Glaxosmithkline Llc. The product's dosage form is tablet, film coated and is administered via form.

    Is NDC 58437-027 included in the NDC Directory?

    Yes, Dolutegravir And Lamivudine is an UNFINISHED PRODUCT with code 58437-027 that is active and included in the NDC Directory. The product was first marketed by Glaxosmithkline Llc on January 01, 2022 and its listing in the NDC Directory is set to expire on December 31, 2025 if the product is not updated or renewed by the manufacturer.

    What is the 11-digit format for NDC 58437-027-00?

    The 11-digit format is 58437002700. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-3-258437-027-005-4-258437-0027-00